LA
NVO

Lee Ainslie’s Novo Nordisk NVO Stock Holding History

Lee Ainslie’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3M Sell
1,653,872
-426,249
-20% -$18.3M 0.7% 40
2026
Q1 		$76.4M Buy
+2,080,121
New +$98.6M 0.88% 36
2024
Q3 		– Sell
-7,849
Closed -$1.12M – 295
2024
Q2 		$1.12M Buy
7,849
+5,744
+273% +$761K 0.02% 206
2024
Q1 		$270K Buy
+2,105
New +$251K 0.01% 362
2023
Q2 		– Sell
-4,312
Closed -$343K – 509
2023
Q1 		$343K Sell
4,312
-296
-6% -$21K 0.01% 382
2022
Q4 		$312K Sell
4,608
-342
-7% -$20.1K 0.01% 275
2022
Q3 		$247K Buy
+4,950
New +$265K 0.01% 274
2021
Q1 		– Sell
-5,316
Closed -$186K – 825
2020
Q4 		$186K Sell
5,316
-12,550
-70% -$434K ﹤0.01% 536
2020
Q3 		$620K Buy
+17,866
New +$596K 0.01% 392

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Lee Ainslie's NVO Position: Q2 2026 in Review

Lee Ainslie reduced its Novo Nordisk (NVO) stake by 20% in Q2 2026, selling an estimated $18.3M and leaving 1,653,872 shares worth $79.3M. The position accounts for 0.7% of the portfolio, ranked #40.

Lee Ainslie first reported a position in NVO in Q3 2020 and has held it in 9 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Lee Ainslie held 1,653,872 shares of Novo Nordisk worth $79.3M as of Q2 2026.
  • Lee Ainslie sold 426,249 Novo Nordisk shares in Q2 2026, an estimated $18.3M.
  • Novo Nordisk made up 0.7% of Lee Ainslie's portfolio in Q2 2026, its #40 holding.
  • Lee Ainslie first reported a position in Novo Nordisk in Q3 2020 and has held it in 9 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.